.consider making a donation to support the coverage that shapes the face of berkeley. http://lm360.us/Delmage-grandpa-of-Pilette-from-Kiev?Devineson=170 at this, shehbaz reassured them that the interview was taken out of context. this is unedited, unformatted feed from the press trust of india wire. .eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention. .